Associations Between Early-Pregnancy Vitamin D Status and Postpartum Depressive and Anxiety Symptoms

Abstract

ABSTRACT Objective Maternal postpartum depressive and anxiety symptoms are risk factors for subsequent maternal and child mental health problems. Little is known about the potential role of antepartum vitamin D and C-reactive protein (CRP) in the etiology of maternal postpartum affective symptoms. We investigated associations between antepartum vitamin D status and postpartum depressive and anxiety symptoms and whether antepartum CRP mediated these associations. Methods In 2483 participants of the Amsterdam Born Children and their Development prospective cohort, maternal serum vitamin D and CRP were measured at a median of 13 weeks’ gestation. Vitamin D status was defined as deficient (≤29.9 nM), insufficient (30–49.9 nM), sufficient (50–79.9 nM), or normal (≥80 nM). Maternal depressive symptoms (Center for Epidemiologic Studies-Depression) and anxiety (State-Trait Anxiety Inventory) were assessed 3 months postpartum. Results After adjustments for confounders, vitamin D deficiency was only associated with increased postpartum anxiety symptoms (B = 0.17, 95% confidence interval [CI] = 0.03–0.30, p = .017) compared to normal vitamin D levels (≥80 nM). In women not taking vitamin D supplementation (n = 2303), vitamin D deficiency was associated with increased postpartum depressive and anxiety symptoms (B = 0.14, 95% CI = 0.03–0.28, p = .045; and B = 0.17, 95% CI = 0.03–0.32, p = .015). Antepartum CRP did not mediate these links. Conclusions We found some evidence that antepartum vitamin D deficiency was associated with increased postpartum affective symptoms, especially in women not taking vitamin D supplementation. Clinical trials should determine whether vitamin D supplementation can reduce the risk for postpartum affective disorders.